All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

41

Reset

41 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • REGN7508CenvacibartPhase 312 trials

    Regeneron · Atrial Fibrillation (AF), Venous Thromboembolism (VTE), Venous Thromboembolism

  • FianlimabREGN3767Phase 311 trials

    Regeneron · Melanoma, Non-small Cell Lung Cancer, Hepatocellular Carcinoma

  • OlatorepatideHS-20094Phase 38 trials

    Jiangsu Hansoh Pharmaceutical Co., Ltd. · Type 2 Diabetes, Overweight or Obesity, Overweight or Obesity Without Diabetes

  • OdronextamabREGN1979, OrdsponoPhase 37 trials

    Regeneron · Follicular Lymphoma (FL), Diffuse Large B-Cell Lymphoma (DLBCL), Relapsed/Refractory Follicular Lymphoma

  • CemdisiranALN-CC5Phase 35 trials

    Regeneron · Paroxysmal Nocturnal Hemoglobinuria, Generalized Myasthenia Gravis, Age-related Macular Degeneration (AMD)

  • MibavademabREGN4461Phase 35 trials

    Regeneron · Generalized Lipodystrophy, Functional Hypothalamic Amenorrhea, FHA

  • REGN9933amrecibartPhase 35 trials

    Regeneron · Atrial Fibrillation (AF), Peripheral Artery Disease (PAD), Venous Thromboembolism (VTE)

  • ALN-CIDEBPhase 34 trials

    Regeneron · Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction-Associated Steatohepatitis, MASLD

  • CMP 001VidutolimodPhase 32 trials

    Pfizer · Advanced Malignancies, NSCLC, Ovarian Cancer

  • REGN1908FreneslerbartPhase 32 trials

    Regeneron · Allergic Conjunctivitis

  • REGN1909MevonlerbartPhase 32 trials

    Regeneron · Allergic Conjunctivitis

  • REGN5713BremzalerbartPhase 31 trial

    Regeneron · Allergic Conjunctivitis

  • REGN5715AtisnolerbartPhase 31 trial

    Regeneron · Allergic Conjunctivitis

  • UbamatamabREGN4018Phase 24 trials

    Regeneron · Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer

  • REGN10597PD-1-IL2Ra-IL2 immunotherapyPhase 23 trials

    Regeneron · Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer

  • REGN5678NezastomigPhase 23 trials

    Regeneron · Metastatic Castration-resistant Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Clear Cell Renal Cell Carcinoma (ccRCC)

  • REGN7075marlotamigPhase 23 trials

    Regeneron · Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer, Metastatic Non Small Cell Lung Cancer

  • ALN-PNPPhase 22 trials

    Regeneron · Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Healthy Volunteers

  • Fianlimab [Fixed ]Phase 22 trials

    Regeneron · Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer

  • REGN4336Phase 22 trials

    Regeneron · Metastatic Castration-resistant Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Clear Cell Renal Cell Carcinoma (ccRCC)

  • REGN5459Vonsetamig, BCMAxCD3Phase 22 trials

    Regeneron · Chronic Kidney Disease (CKD), Relapsed Multiple Myeloma, Refractory Multiple Myeloma

  • REGN7544baloncibartPhase 22 trials

    Regeneron · Postural Orthostatic Tachycardia Syndrome (POTS), Sepsis-Induced Hypotension

  • ALN-6457ALN-PRNPPhase 21 trial

    Regeneron · Prion Disease

  • BNT116Phase 21 trial

    Regeneron · Advanced Non-Small Cell Lung Cancer

  • FDC fianlimabPhase 21 trial

    Regeneron · Head and Neck Squamous Cell Carcinoma (HNSCC)

  • Fixed cemiplimabPhase 21 trial

    Regeneron · Melanoma

  • LNP1265Phase 21 trial

    Regeneron · Hemophilia B

  • REGN13089-M404-M2980Phase 21 trial

    Regeneron · Advanced Solid Tumors

  • REGN13335Phase 21 trial

    Regeneron · Pulmonary Arterial Hypertension (PAH)

  • REGN15505Phase 21 trial

    Regeneron · Metastatic Castration-Resistant Prostate Cancer (mCRPC), Clear Cell Renal Cell Carcinoma (ccRCC)

  • REGN17372Phase 21 trial

    Regeneron · Relapsed Refractory Multiple Myeloma (RRMM)

  • REGN21353Phase 21 trial

    Regeneron · Metastatic Castration-Resistant Prostate Cancer, mCRPC

  • REGN22530Phase 21 trial

    Regeneron · Primary Open Angle Glaucoma (POAG), Ocular Hypertension (OHT)

  • REGN5093davutamigPhase 21 trial

    Regeneron · NSCLC

  • REGN5381Phase 21 trial

    Regeneron · Heart Failure

  • REGN5668ubletamigPhase 21 trial

    Regeneron · Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer

  • REGN7945Phase 21 trial

    Regeneron · Relapsed/Refractory Multiple Myeloma

  • REGN7999Phase 21 trial

    Regeneron · Non-Transfusion Dependent Beta-Thalassemia (NTDT)

  • REGN9220Phase 21 trial

    Regeneron · Diffuse Large B-Cell Lymphoma (DLBCL)

  • REGV131Phase 21 trial

    Regeneron · Hemophilia B

  • TrevogrumabREGN1033, GDF8Phase 21 trial

    Regeneron · Obesity

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.